Atara Biotherapeutics, Inc. · NASDAQ:ATRA
Panacea Venture Healthcare Fund II, L.P. reported a 9.50% stake in Atara Biotherapeutics, Inc. (Schedule 13G)
Event Jan 30, 2025 · Filed Feb 6, 2025
Panacea Venture Healthcare Fund II, L.P. reported a 9.50% stake in Atara Biotherapeutics, Inc., 550,000 shares, as a passive investor on Jan 30, 2025. Filed Feb 6, 2025 (Schedule 13G).
- Stake
- 9.50%
- Shares
- 550,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Panacea Venture Healthcare Fund II, L.P. | 9.50% | 550,000 |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 9.50% | 550,000 |
| Panacea Innovation Limited | 9.50% | 550,000 |
| James Huang | 9.50% | 550,000 |
Source
Related
- Atara Biotherapeutics, Inc.
- Panacea Innovation Ltd
- Atara Biotherapeutics, Inc. shareholders
- Form 4 · Cherry Brian N · Sep 4, 2026
- Form 4 · Nguyen AnhCo · Aug 26, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Form 4 · Redmile Group, LLC · Jul 24, 2026
- Schedule 13D/A · Redmile Group, LLC · Jul 24, 2026